SCHEMBL1861291

SCHEMBL1861291

O=C1[N]CCNC1(c1ccccc1)c1cccnc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 4/20 0.36
LMNA P02545 1/20 0.36
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
CYP19A1 P11511 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
MAPT P10636 3/20 0.34
VNN1 O95497 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
CACNA1F O60840 1/20 0.33
CYP2C9 P11712 1/20 0.33
HTR2A P28223 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11683981 0.70 CYP2C9 (0.71) CYP3A4ALDH1A1MAPTCACNA1FCYP2C9
SCHEMBL1864208 0.67 CYP3A4 (0.43) CYP3A4ALDH1A1LMNAHCAR2VNN1
SCHEMBL11884797 0.64 CYP2C9 (0.47) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL8675159 0.63 LMNA (0.35) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL7525878 0.63 OPRM1 (0.69) CYP3A4ALDH1A1LMNAVNN1MEN1
SCHEMBL1865507 0.62 ALDH1A1 (0.42) CYP3A4ALDH1A1LMNACYP11B1CYP11B2
SCHEMBL246083 0.62 CHRNB2 (0.43) CYP3A4ALDH1A1LMNAHCAR2CYP1A2
SCHEMBL1860147 0.62 HTR2A (0.38) CYP3A4ALDH1A1LMNAHCAR2VNN1
SCHEMBL1866073 0.62 HTR2A (0.38) CYP3A4ALDH1A1LMNAHCAR2VNN1
SCHEMBL11240260 0.62 VNN1 (0.43) ALDH1A1LMNAHCAR2VNN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011053705-A1 PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-05-05 WO disclosed